Médecins Sans Frontières has launched a tool kit for costing clinical research and is urging others to use it to increase transparency

MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy

The EDCTP partnership that sponsors clinical trials in Africa is a flagship of the EU’s health research effort. But as it reaches its 20 anniversary the pending pharmaceutical legislation and budget worries dog its future, warns Maria da Graça Carvalho MEP

Forty new rare disease programmes entering the clinic over the next decade. This is the goal of a new collaboration between Oxford University and the Harrington Discovery Institute, which aims to put up to £200M into getting projects out academic labs and into clinical development  

Experts are calling for more regulatory action to bring precision medicine to the market, as big data enables more personalised treatments and prevention

A drop off in the number of commercially led trials has had an opportunity cost for UK taxpayers of an estimated £360 million over the past five years, says government commissioned review

The EU came up short in running any pan-European clinical trials to advance the development of COVID-19 vaccines and therapies. It is now trying to fix the problem and be better prepared for future health emergencies

Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

A report by the European Parliament’s cancer special committee says the EU needs better coordination of cross-border clinical trials